Cancer researchers use supercomputer to gain insight into new treatment technology

August 27, 2014 by Makeda Easter, University of Texas at Austin
Credit: Texas Advanced Computing Center

Cancer radiation treatment is a tricky process. Medical researchers and physicians must walk the delicate line of delivering just enough radiation to kill tumors while sparing surrounding healthy tissue.

Current treatment relies on imaging from computed tomography (CT) scans, which are taken prior to treatment to determine the tumor's location. This method works fairly well if the tumor lies in an easily detectable and immobile location.

But let's say a patient has lung cancer and will soon undergo . CT scans do not provide real-time imaging of the tumor and in this case, the tumor is constantly moving due to the patient's breathing. The doctor might end up irradiating a large portion of the lung unnecessarily, which could destroy the tumor, but could also lead to a lower quality of life due to effects like difficulty breathing and reduced mobility.

One group, the Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy, is tackling this issue by developing a potentially significant improvement over current technology, the MRI-linac.

The new system unites and magnetic resonance imaging (MRI), allowing physicians to view the tumor in real-time and in high detail during treatment. It also permits physicians to adapt the radiation treatment during the procedure, sparing healthy tissue and reducing side effects.

Like putting together a complicated puzzle, building the MRI-linac relies on many pieces. The research consortium comprises corporations, hospitals, universities, and research institutions worldwide, all of which contribute the distinct research components necessary to develop this technology.

As part of a checks and balances system, one research project at the MD Anderson Cancer Center in Houston focuses on dosimetry—tracking how much radiation is being delivered through the new radiotherapy device.

"Precise knowledge of dose is critical to effective radiation treatment," said Michelle Mathis, a medical physics researcher for the MD Anderson dosimetry team.

Cancer researchers use supercomputer to gain insight into new treatment technology
This image shows one of the ionization chamber models plotted through the Geant4 software. Using a Geant4 toolkit, the researchers can precisely simulate electron motion in both an electric and magnetic field, allowing them to understand the impact of the magnetic field on radiation dose distribution. Credit: MD Anderson Cancer Center

"Different tumors need different doses to be killed," Mathis said. "Our work focuses on gaining a better understanding of how to precisely calibrate the new MRI-linac system so that the appropriate amount of radiation is delivered to the cancer tumor while healthy tissue is spared."

Delivering the Right Dose Using Ionization Chambers

Radiation therapy is typically administered through a linear accelerator, or linac. Inside the linac, electrons are sped up, faster and faster, through an electric field, until they're traveling at nearly the speed of light. Once the electrons reach this speed they hit a target, creating radiation. The radiation is then shaped in the linac, and sprayed down to target the tumor in a patient's body.

Medical physicists use a type of radiation detector called an ionization chamber to ensure that the radiation dose delivered is accurate. Ionization chambers are a necessary part of dose measurement, allowing medical physicists to calibrate the linac.

However, integrating radiation therapy and MRI into a single system adds a , which adds a new layer of complication to the performance of ionization chambers.

"In order to adjust for the presence of a magnetic field, we are developing correction factors so that ionization chambers can be used to calibrate the amount of radiation delivered by the new MRI-linac system," Mathis said.

Since only one prototype of the MRI-linac system is available, Mathis performs supercomputer simulations to model radiation in a magnetic field.

The Texas Advanced Computing Center (TACC) at The University of Texas at Austin provides the necessary support to Mathis' research to run these simulations. Through the UT System Research Cyberinfrastructure (UTRC), an initiative that allows any of the 15 University of Texas System institutions access to TACC's supercomputing resources, the team runs simulations on Lonestar, a powerful, high performance computing and remote visualization resource.

"Using Lonestar, we are able to simulate the effect of many variables on the ionization chamber readings, which will allow us to precisely calculate ," Mathis said.

"Many institutions have their own clusters, however, their machines aren't as powerful or well-maintained as TACC's," said John Fonner, a research associate in TACC's Life Sciences Computing Group. "And because TACC staff are professionals in the advanced computing world, they can provide the technical expertise that other institutions can't, allowing researchers to take their projects to the next level."

The MD Anderson dosimetry team is using a total of 250,000 hours on Lonestar and will continue to run simulations until they can develop correction factors for 16 different ionization chambers.

"By running the supercomputer simulations, our goal is to understand how to properly use ionization chambers in the presence of a magnetic field," Mathis said. "The results of our research will facilitate safe use of the MRI-linac systems, which in turn will be used to treat cancer patients more effectively."

The new MRI-linac has not been released, but the pieces are starting to come together. Several institutions in the consortium have recently been installing initial components. Mathis' dosimetry team will continue working to better understand the system and ensure it functions as intended.

Said Mathis: "Cancer is a global issue, so it's nice to take a holistic approach in improving technology to treat it—ultimately saving more lives and ensuring a better overall quality of life for those affected by cancer."

Explore further: New technology to allow simultaneous tumour imaging and radiotherapy treatment

Related Stories

New technology to allow simultaneous tumour imaging and radiotherapy treatment

June 5, 2014
The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust will be the first in the UK to gain access to a state-of-the-art radiotherapy system after entering into a pioneering research collaboration ...

New diagnostic imaging techniques deemed safe in simulations

June 4, 2014
Gamma and neutron imaging offer possible improvements over existing techniques such as X-ray or CT, but their safety is not yet fully understood. Using computer simulations, imaging the liver and breast with gamma or neutron ...

Protein ZEB1 promotes breast tumor resistance to radiation therapy

August 4, 2014
Twist, Snail, Slug. They may sound like words in a children's nursery rhyme, but they are actually the exotic names given to proteins that can generate cells with stem cell-like properties that have the ability to form diverse ...

Doctors treat deep brain tumor with novel MRI-guided laser technology

February 25, 2014
Using a novel magnetic resonance imaging (MRI)-guided laser technology, neurosurgeons at UC San Diego Health System have successfully treated a malignant tumor deep inside a patient's brain. This is the first time that this ...

Recommended for you

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Scientists block the siren call of two aggressive cancers

January 23, 2018
Aggressive cancers like glioblastoma and metastatic breast cancer have in common a siren call that beckons the bone marrow to send along whatever the tumors need to survive and thrive.

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

Workouts may boost life span after breast cancer

January 22, 2018
(HealthDay)—Longer survival after breast cancer may be as simple as staying fit, new research shows.

Cancer patients who tell their life story find more peace, less depression

January 22, 2018
Fifteen years ago, University of Wisconsin–Madison researcher Meg Wise began interviewing cancer patients nearing the end of life about how they were living with their diagnosis. She was surprised to find that many asked ...

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.